Task: Answer the multiple-choice question.
Question: Which drug exhibits a -16.436\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
[a] CC(C)NCCCOc1ccc(Cl)cc1Br.O=C(O)C(=O)O
[b] O=C(NC(=S)Nc1cnc2ccccc2c1)c1ccccc1
[c] O=C(Nc1ccc2oc(-c3cccnc3)nc2c1)c1cc2ccccc2o1
Answer: a. CC(C)NCCCOc1ccc(Cl)cc1Br.O=C(O)C(=O)O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
3-(2-bromo-4-chlorophenoxy)-N-propan-2-ylpropan-1-amine;oxalic acid